SEC FORM 4
$9,696.07
Bolt Biotherapeutics, Inc. (BOLT)
Sale of 2,922 shares at $3.3183 per share.
Reporting Person Nemec Sarah · Officer Title Senior VP, Finance and PAO · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001193125-26-396892 · filed 2026-09-21 · View filing →